Adoptive transfer of wild-type CD8+ T cells partially improves disease outcome in Theiler’s murine encephalomyelitis virus-infected OT-I mice

Theiler’s murine encephalomyelitis virus (TMEV) represents a well-established experimental model for the progressive form of multiple sclerosis in susceptible SJL mice. In contrast, resistant C57BL/6 mice are able to completely clear the virus. Our previous data showed that OT-I mice on a resistant C57BL/6-background, which express an MHC-I-restricted T cell receptor specific for the chicken ovalbumin, are rendered susceptible to experimental intracerebral infection with TMEV. They also showed viral spread into the spinal cord due to an impaired T cell response. Because CD8 + T cells substantially contribute to anti-viral adaptive immune responses, we investigated whether an adoptive transfer of CD8 + T cells with a fully functional T cell receptor repertoire may modify the disease course of TMEV in OT-I mice regarding clinical progression and pathological manifestation. We assessed clinical progression and histomorphologic changes, evaluated T cell activation and migration by flow cytometry, and performed neurofilament light chain serum analysis. Viral load was quantified by immunohistochemistry and gene expression by RNA sequencing. Transfer of 5 × 10 6 CD8 + T cells into TMEV-infected OT-I mice attenuated clinical progression, significantly increased survival, and reduced clinical score, viral load, and inflammatory score. Flow cytometry revealed that transferred red fluorescent protein -CD8 + T cells constituted the majority of activated/effectorCD8 + T cells in the brain, and RNA sequencing confirmed the enhancement of an ongoing adaptive immune response. However, a complete rescue and long-term survival of TMEV-infected OT-I mice could not be achieved.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-19
DOI
https://doi.org/10.3389/fimmu.2026.1963521
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Adoptive transfer of wild-type CD8+ T cells partially improves disease outcome in Theiler’s murine encephalomyelitis virus-infected OT-I mice

Alexander Flügel, Rouven Wannemacher, Felix Stegmann, Fred Lühder et al.
Frontiers in Immunology
Multiple Sclerosis Research Studies
article

Adoptive transfer of wild-type CD8+ T cells partially improves disease outcome in Theiler’s murine encephalomyelitis virus-infected OT-I mice

Alexander Flügel, Rouven Wannemacher, Felix Stegmann, Fred Lühder, Bernd Lepenies, Klaus Schughart, Wolfgang Baumgärtner, Kirsten Hülskötter, Virginie Sippel, Robert Geffers, Michel Alexander Steiner, Karl Röhn, Anna Segna, Mara Lombardo, Charlotte Kinder
article en

Abstract

Theiler’s murine encephalomyelitis virus (TMEV) represents a well-established experimental model for the progressive form of multiple sclerosis in susceptible SJL mice. In contrast, resistant C57BL/6 mice are able to completely clear the virus. Our previous data showed that OT-I mice on a resistant C57BL/6-background, which express an MHC-I-restricted T cell receptor specific for the chicken ovalbumin, are rendered susceptible to experimental intracerebral infection with TMEV. They also showed viral spread into the spinal cord due to an impaired T cell response. Because CD8 + T cells substantially contribute to anti-viral adaptive immune responses, we investigated whether an adoptive transfer of CD8 + T cells with a fully functional T cell receptor repertoire may modify the disease course of TMEV in OT-I mice regarding clinical progression and pathological manifestation. We assessed clinical progression and histomorphologic changes, evaluated T cell activation and migration by flow cytometry, and performed neurofilament light chain serum analysis. Viral load was quantified by immunohistochemistry and gene expression by RNA sequencing. Transfer of 5 × 10 6 CD8 + T cells into TMEV-infected OT-I mice attenuated clinical progression, significantly increased survival, and reduced clinical score, viral load, and inflammatory score. Flow cytometry revealed that transferred red fluorescent protein -CD8 + T cells constituted the majority of activated/effectorCD8 + T cells in the brain, and RNA sequencing confirmed the enhancement of an ongoing adaptive immune response. However, a complete rescue and long-term survival of TMEV-infected OT-I mice could not be achieved.

Frontiers in ImmunologyVol. 17
University of Tennessee Health Science Center (US), University of Veterinary Medicine Hannover, Foundation (DE), University of Münster (DE), Universitätsmedizin Göttingen (DE), Helmholtz Centre for Infection Research (DE), Hannover Re (Germany) (DE), Idorsia Pharmaceuticals Ltd (Switzerland) (CH)
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon